Company · BCDA
BioCardia, Inc.
Nasdaq's symbol directory lists BCDA on Nasdaq as “BioCardia, Inc. - Common Stock”.
In the 12 months to Nov 8, 2026: insiders bought on 18 occasions ($137K); 7 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- STERTZER SIMON H bought $104K
- Peter Altman, President and CEO bought $34K
Every trade (18)
- BUYPeter Altman, President and CEO bought $285
- BUYPeter Altman, President and CEO bought $190
- BUYPeter Altman, President and CEO bought $1K
- BUYPeter Altman, President and CEO bought $2K
- BUYPeter Altman, President and CEO bought $872
- BUYPeter Altman, President and CEO bought $5K
- BUYPeter Altman, President and CEO bought $2K
- BUYPeter Altman, President and CEO bought $4K
- BUYPeter Altman, President and CEO bought $415
- BUYPeter Altman, President and CEO bought $1K
- BUYPeter Altman, President and CEO bought $2K
- BUYPeter Altman, President and CEO bought $940
- BUYPeter Altman, President and CEO bought $900
- BUYPeter Altman, President and CEO bought $11K
- BUYSTERTZER SIMON H bought $39K
- BUYSTERTZER SIMON H bought $65K
- BUYPeter Altman, President and CEO bought $768
- BUYPeter Altman, President and CEO bought $1K
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Other events Nov 6, 2026
- Other events Oct 19, 2026
- Other events Oct 7, 2026
- Other events Oct 1, 2026
- Other events Sep 23, 2026
- Other events Sep 21, 2026
- Other events Sep 10, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.